Literature DB >> 11333121

The body site distribution of melanocytic naevi in 6-7 year old European children.

P Autier1, M Boniol, G Severi, G Giles, M S Cattaruzza, H Luther, F Renard, A R Grivegnée, R Pedeux, J F Doré.   

Abstract

The number and size of melanocytic naevi are the main predictors of cutaneous melanoma. Naevus development per unit of skin surface is greatest during childhood. We assessed the body distribution of naevi 2-4.9 mm and > or = 5 mm in 649 European children aged 6-7 years old from Brussels (Belgium), Bochum (Germany), Lyon (France) and Rome (Italy). The numbers of naevi 2-4.9 mm and naevi > or = 5 mm were strongly correlated, especially on the trunk. For naevi 2-4.9 mm, the highest relative densities were found on the face, back, shoulders and the external surface of the arms. The lowest relative densities were found on the hands, legs, feet and abdomen. The relative density of naevi > or = 5 mm was higher on the trunk than on any other body site. Similar body distributions were observed in both sexes and at each centre. The body site distribution of naevi 2-4.9 mm seemed to parallel the usual sun exposure patterns of young European children. It is suggested that the development of naevi > or = 5 mm might be a marker of the vulnerability of melanocytes to the harmful effects of solar radiation. Vulnerability would be maximal on the back, and would decrease from proximal to distal skin areas, with melanocytes of the hands and feet having the lowest vulnerability. The number of naevi acquired on a specific area of skin would result from the combined effects of local vulnerability to solar radiation and local sun exposure history. The origin of acquired body site differences in the susceptibility of melanocytes to ultraviolet radiation is unknown, although it seems to parallel the body site density of sensory innervation.

Entities:  

Mesh:

Year:  2001        PMID: 11333121     DOI: 10.1097/00008390-200104000-00006

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  10 in total

1.  Sorafenib-induced eruptive melanocytic lesions.

Authors:  Heidi H Kong; Vincent Sibaud; Maria L Chanco Turner; Tito Fojo; Thomas J Hornyak; Christine Chevreau
Journal:  Arch Dermatol       Date:  2008-06

2.  Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma.

Authors:  Nancy E Thomas; Sharon N Edmiston; Peter A Kanetsky; Klaus J Busam; Anne Kricker; Bruce K Armstrong; Anne E Cust; Hoda Anton-Culver; Stephen B Gruber; Li Luo; Irene Orlow; Anne S Reiner; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Lidia Sacchetto; Terence Dwyer; Eloise A Parrish; Honglin Hao; David C Gibbs; Jill S Frank; David W Ollila; Colin B Begg; Marianne Berwick; Kathleen Conway
Journal:  J Invest Dermatol       Date:  2017-08-24       Impact factor: 8.551

3.  Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.

Authors:  David C Gibbs; Irene Orlow; Jennifer I Bramson; Peter A Kanetsky; Li Luo; Anne Kricker; Bruce K Armstrong; Hoda Anton-Culver; Stephen B Gruber; Loraine D Marrett; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Terence Dwyer; Ajay Sharma; Emily La Pilla; Lynn From; Klaus J Busam; Anne E Cust; David W Ollila; Colin B Begg; Marianne Berwick; Nancy E Thomas
Journal:  J Natl Cancer Inst       Date:  2016-02-08       Impact factor: 13.506

Review 4.  Body Site Distribution of Acquired Melanocytic Naevi and Associated Characteristics in the General Population of Caucasian Adults: A Scoping Review.

Authors:  Dilki Jayasinghe; Kaitlin L Nufer; Brigid Betz-Stablein; H Peter Soyer; Monika Janda
Journal:  Dermatol Ther (Heidelb)       Date:  2022-09-30

5.  Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes.

Authors:  Nancy E Thomas; Sharon N Edmiston; Irene Orlow; Peter A Kanetsky; Li Luo; David C Gibbs; Eloise A Parrish; Honglin Hao; Klaus J Busam; Bruce K Armstrong; Anne Kricker; Anne E Cust; Hoda Anton-Culver; Stephen B Gruber; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Lidia Sacchetto; Terence Dwyer; David W Ollila; Colin B Begg; Marianne Berwick; Kathleen Conway
Journal:  J Invest Dermatol       Date:  2018-05-09       Impact factor: 8.551

6.  Appearance of New Vemurafenib-associated Melanocytic Nevi on Normal-appearing Skin: Case Series and a Review of Changing or New Pigmented Lesions in Patients with Metastatic Malignant Melanoma After Initiating Treatment with Vemurafenib.

Authors:  Philip R Cohen; Agop Y Bedikian; Kevin B Kim
Journal:  J Clin Aesthet Dermatol       Date:  2013-05

7.  Melanocytic nevi and sun exposure in a cohort of colorado children: anatomic distribution and site-specific sunburn.

Authors:  Athena T Dodd; Joseph Morelli; Stefan T Mokrohisky; Nancy Asdigian; Tim E Byers; Lori A Crane
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-10       Impact factor: 4.254

8.  Study of Nevi in Children (SONIC): baseline findings and predictors of nevus count.

Authors:  Susan A Oliveria; Jaya M Satagopan; Alan C Geller; Stephen W Dusza; Martin A Weinstock; Marianne Berwick; Marilyn Bishop; Maureen K Heneghan; Allan C Halpern
Journal:  Am J Epidemiol       Date:  2008-11-10       Impact factor: 4.897

9.  A case with postchemotherapy eruptive compound nevus.

Authors:  Selma Bakar Dertlioglu; Muharrem Bitiren; Demet Cicek
Journal:  Indian J Dermatol       Date:  2011-11       Impact factor: 1.494

10.  Association between melanocytic nevi and risk of breast diseases: The French E3N prospective cohort.

Authors:  Marina Kvaskoff; Anne Bijon; Sylvie Mesrine; Alice Vilier; Laura Baglietto; Agnès Fournier; Françoise Clavel-Chapelon; Laure Dossus; Marie-Christine Boutron-Ruault
Journal:  PLoS Med       Date:  2014-06-10       Impact factor: 11.069

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.